167 related articles for article (PubMed ID: 28932647)
1. Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms.
Jahangir A; Chandra D; Quispe-Tintaya W; Singh M; Selvanesan BC; Gravekamp C
Oncoimmunology; 2017; 6(9):e1342025. PubMed ID: 28932647
[TBL] [Abstract][Full Text] [Related]
2. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.
Chandra D; Jahangir A; Quispe-Tintaya W; Einstein MH; Gravekamp C
Br J Cancer; 2013 Jun; 108(11):2281-90. PubMed ID: 23640395
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer.
Castro F; Leal B; Denny A; Bahar R; Lampkin S; Reddick R; Lu S; Gravekamp C
Br J Cancer; 2009 Oct; 101(8):1329-37. PubMed ID: 19826426
[TBL] [Abstract][Full Text] [Related]
5. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
8. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
9. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.
D'Orazio SE; Halme DG; Ploegh HL; Starnbach MN
J Immunol; 2003 Jul; 171(1):291-8. PubMed ID: 12817010
[TBL] [Abstract][Full Text] [Related]
10. Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.
Chandra D; Jahangir A; Cornelis F; Rombauts K; Meheus L; Jorcyk CL; Gravekamp C
Oncoimmunology; 2016; 5(1):e1049802. PubMed ID: 26942057
[TBL] [Abstract][Full Text] [Related]
11. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
[TBL] [Abstract][Full Text] [Related]
14. Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination.
Hulett TW; Jensen SM; Wilmarth PA; Reddy AP; Ballesteros-Merino C; Afentoulis ME; Dubay C; David LL; Fox BA
J Immunother Cancer; 2018 Apr; 6(1):27. PubMed ID: 29618380
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
16. Behavior of metastatic and nonmetastatic breast tumors in old mice.
Gravekamp C; Sypniewska R; Gauntt S; Tarango M; Price P; Reddick R
Exp Biol Med (Maywood); 2004 Jul; 229(7):665-75. PubMed ID: 15229361
[TBL] [Abstract][Full Text] [Related]
17. An H2-T MHC class Ib molecule presents Listeria monocytogenes-derived antigen to immune CD8+ cytotoxic T cells.
Bouwer HG; Lindahl KF; Baldridge JR; Wagner CR; Barry RA; Hinrichs DJ
J Immunol; 1994 Jun; 152(11):5352-60. PubMed ID: 8189053
[TBL] [Abstract][Full Text] [Related]
18. Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers.
Brinkhoff B; Ostroumov D; Heemcke J; Woller N; Gürlevik E; Manns MP; Longerich T; Zender L; Harty JT; Kubicka S; Kühnel F; Wirth TC
Eur J Immunol; 2014 Apr; 44(4):1213-24. PubMed ID: 24338782
[TBL] [Abstract][Full Text] [Related]
19. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.
Pulaski BA; Terman DS; Khan S; Muller E; Ostrand-Rosenberg S
Cancer Res; 2000 May; 60(10):2710-5. PubMed ID: 10825145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
